98 related articles for article (PubMed ID: 11408360)
1. Methadone inhibits rhodamine123 transport in Caco-2 cells.
Störmer E; Perloff MD; von Moltke LL; Greenblatt DJ
Drug Metab Dispos; 2001 Jul; 29(7):954-6. PubMed ID: 11408360
[TBL] [Abstract][Full Text] [Related]
2. Transport of rhodamine 123, a P-glycoprotein substrate, across rat intestine and Caco-2 cell monolayers in the presence of cytochrome P-450 3A-related compounds.
Yumoto R; Murakami T; Nakamoto Y; Hasegawa R; Nagai J; Takano M
J Pharmacol Exp Ther; 1999 Apr; 289(1):149-55. PubMed ID: 10086998
[TBL] [Abstract][Full Text] [Related]
3. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.
Sachs-Barrable K; Thamboo A; Lee SD; Wasan KM
J Pharm Pharm Sci; 2007; 10(3):319-31. PubMed ID: 17727795
[TBL] [Abstract][Full Text] [Related]
4. Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana.
Zhu HJ; Wang JS; Markowitz JS; Donovan JL; Gibson BB; Gefroh HA; Devane CL
J Pharmacol Exp Ther; 2006 May; 317(2):850-7. PubMed ID: 16439618
[TBL] [Abstract][Full Text] [Related]
5. Thalidomide does not interact with P-glycoprotein.
Zimmermann C; Gutmann H; Drewe J
Cancer Chemother Pharmacol; 2006 May; 57(5):599-606. PubMed ID: 16136308
[TBL] [Abstract][Full Text] [Related]
6. Expression and functional activity of P-glycoprotein in passaged primary human nasal epithelial cell monolayers cultured by the air-liquid interface method for nasal drug transport study.
Cho HJ; Choi MK; Lin H; Kim JS; Chung SJ; Shim CK; Kim DD
J Pharm Pharmacol; 2011 Mar; 63(3):385-91. PubMed ID: 21749386
[TBL] [Abstract][Full Text] [Related]
7. Effects of Schisandra lignans on P-glycoprotein-mediated drug efflux in human intestinal Caco-2.
Yoo HH; Lee M; Lee MW; Lim SY; Shin J; Kim DH
Planta Med; 2007 May; 73(5):444-50. PubMed ID: 17566147
[TBL] [Abstract][Full Text] [Related]
8. Permeability modulation of human intestinal Caco-2 cell monolayers by interferons.
Kawaguchi H; Akazawa Y; Watanabe Y; Takakura Y
Eur J Pharm Biopharm; 2005 Jan; 59(1):45-50. PubMed ID: 15567300
[TBL] [Abstract][Full Text] [Related]
9. P-glycoprotein is not involved in the differential oral potency of naloxone and naltrexone.
Kanaan M; Daali Y; Dayer P; Desmeules J
Fundam Clin Pharmacol; 2009 Oct; 23(5):543-8. PubMed ID: 19656202
[TBL] [Abstract][Full Text] [Related]
10. Transport characteristics of rutin deca (H-) sulfonate sodium across Caco-2 cell monolayers.
He Y; Zeng S
J Pharm Pharmacol; 2005 Oct; 57(10):1297-303. PubMed ID: 16259758
[TBL] [Abstract][Full Text] [Related]
11. Caco-2 cell methodology and inhibition of the P-glycoprotein transport of digoxin by Aloe vera juice.
Djuv A; Nilsen OG
Phytother Res; 2008 Dec; 22(12):1623-8. PubMed ID: 19003953
[TBL] [Abstract][Full Text] [Related]
12. Risperidone and paliperidone inhibit p-glycoprotein activity in vitro.
Zhu HJ; Wang JS; Markowitz JS; Donovan JL; Gibson BB; DeVane CL
Neuropsychopharmacology; 2007 Apr; 32(4):757-64. PubMed ID: 16936711
[TBL] [Abstract][Full Text] [Related]
13. Permeation of astilbin and taxifolin in Caco-2 cell and their effects on the P-gp.
Wang XD; Meng MX; Gao LB; Liu T; Xu Q; Zeng S
Int J Pharm; 2009 Aug; 378(1-2):1-8. PubMed ID: 19465099
[TBL] [Abstract][Full Text] [Related]
14. Effects of diosmin, a flavonoid glycoside in citrus fruits, on P-glycoprotein-mediated drug efflux in human intestinal Caco-2 cells.
Yoo HH; Lee M; Chung HJ; Lee SK; Kim DH
J Agric Food Chem; 2007 Sep; 55(18):7620-5. PubMed ID: 17676865
[TBL] [Abstract][Full Text] [Related]
15. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity.
Taub ME; Podila L; Ely D; Almeida I
Drug Metab Dispos; 2005 Nov; 33(11):1679-87. PubMed ID: 16093365
[TBL] [Abstract][Full Text] [Related]
16. P-glycoprotein interactions of nefazodone and trazodone in cell culture.
Störmer E; von Moltke LL; Perloff MD; Greenblatt DJ
J Clin Pharmacol; 2001 Jul; 41(7):708-14. PubMed ID: 11452702
[TBL] [Abstract][Full Text] [Related]
17. Echinacea purpurea and P-glycoprotein drug transport in Caco-2 cells.
Hansen TS; Nilsen OG
Phytother Res; 2009 Jan; 23(1):86-91. PubMed ID: 18688789
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of P-glycoprotein-mediated transport by terpenoids contained in herbal medicines and natural products.
Yoshida N; Koizumi M; Adachi I; Kawakami J
Food Chem Toxicol; 2006 Dec; 44(12):2033-9. PubMed ID: 16904803
[TBL] [Abstract][Full Text] [Related]
19. Apparent active transport of MDMA is not mediated by P-glycoprotein: a comparison with MDCK and Caco-2 monolayers.
Bertelsen KM; Greenblatt DJ; von Moltke LL
Biopharm Drug Dispos; 2006 Jul; 27(5):219-27. PubMed ID: 16552717
[TBL] [Abstract][Full Text] [Related]
20. Polymethoxylated flavones and other phenolic derivates from citrus in their inhibitory effects on P-glycoprotein-mediated transport of talinolol in Caco-2 cells.
Mertens-Talcott SU; De Castro WV; Manthey JA; Derendorf H; Butterweck V
J Agric Food Chem; 2007 Apr; 55(7):2563-8. PubMed ID: 17348674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
